Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven L Allen

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Haematologica|November 8, 2011
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevancePreetesh Jain, Mohammad Javdan, Franziska K Feger, et al.
Molecular Medicine (Cambridge, Mass.)|November 15, 2008
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidationRosa Catera, Gregg J Silverman, Katerina Hatzi, et al.
Blood|June 5, 2010
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808Jonathan E Kolitz, Stephen L George, Guido Marcucci, et al.
Blood|March 10, 2011
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the diseaseDavide Bagnara, Matthew S Kaufman, Carlo Calissano, et al.
Cancer|January 3, 2014
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808Jonathan E Kolitz, Stephen L George, Don M Benson, et al.
Frontiers in Oncology|June 11, 2021
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical CourseDavide Bagnara, Catherine Tang, Jennifer R Brown, et al.
Blood|October 17, 2012
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsPiers E M Patten, Charles C Chu, Emilia Albesiano, et al.
Immunologic Research|August 31, 2015
A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytesBrian A McCarthy, Sophia Yancopoulos, Mike Tipping, et al.
Frontiers in Immunology|September 8, 2025
Conventional and non-conventional antigen-binding sites promote the development and function of chronic lymphocytic leukemia stereotyped subset #4 clonesYun Liu, Dzmitry Padhorny, Rosa Catera, et al.
Leukemia|May 3, 2021
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLLGerardo Ferrer, Byeongho Jung, Pui Yan Chiu, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Haematologica|November 8, 2011
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevancePreetesh Jain, Mohammad Javdan, Franziska K Feger, et al.
Molecular Medicine (Cambridge, Mass.)|November 15, 2008
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidationRosa Catera, Gregg J Silverman, Katerina Hatzi, et al.
Blood|June 5, 2010
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808Jonathan E Kolitz, Stephen L George, Guido Marcucci, et al.
Blood|March 10, 2011
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the diseaseDavide Bagnara, Matthew S Kaufman, Carlo Calissano, et al.
Cancer|January 3, 2014
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808Jonathan E Kolitz, Stephen L George, Don M Benson, et al.
Frontiers in Oncology|June 11, 2021
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical CourseDavide Bagnara, Catherine Tang, Jennifer R Brown, et al.
Blood|October 17, 2012
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsPiers E M Patten, Charles C Chu, Emilia Albesiano, et al.
Immunologic Research|August 31, 2015
A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytesBrian A McCarthy, Sophia Yancopoulos, Mike Tipping, et al.
Frontiers in Immunology|September 8, 2025
Conventional and non-conventional antigen-binding sites promote the development and function of chronic lymphocytic leukemia stereotyped subset #4 clonesYun Liu, Dzmitry Padhorny, Rosa Catera, et al.
Leukemia|May 3, 2021
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLLGerardo Ferrer, Byeongho Jung, Pui Yan Chiu, et al.
Pageof 9